RE:RE:BiogenMore than 3 years ago they were presenting there theory of toxic oligomers to pharma companies "supposedly", while Biogen initiated two large phase 3 trials in 2015 and was the front runner with it's Aducanumab. A lot of time before march of this year for pharma to strike a deal if Promis is the real deal. Didn't happen!! Been talking about potential partnering for better than 3 years? No deals? PD more than a year and half ago "We are actively pursuing discussions with large pharma regarding partnering of these two new toxic oligomer programs. Clearly missed the IND filing deadline posted a couple of years ago.
If they had the real deal they would have a deal by now, instead of feeding the nonsense these things take time.
Financing are beginnng to look like a pyramid scheme with the same playes at the table.